Clinical trials recruiting for Immune-related Adverse Event
3
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Mesalamine | 1 |
| Thymosin Alpha 1 and Anti-PD-1 monoclonal antibody | 1 |
Self-screener
Recruiting trials
- Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
- Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
- Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma
Related conditions
Trials recruiting for Immune-related Adverse Event often also study these conditions. Each links to its own recruiting-trial list.
Melanoma 487Neoadjuvant Therapy 23Immune Checkpoint Inhibitor 8dMMR Colorectal Cancer 3Diarrhea 4Colorectal cancer 1359Advanced Melanoma 23
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Immune-related Adverse Event trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.